Clinical trial data: The safety of Ketoconazole (Nizoral) Shampoo 2% was evaluated in 2890 subjects in 22 clinical trials where Ketoconazole (Nizoral) Shampoo 2% was administered topically to the scalp and/or skin. No adverse reactions were reported in ≥1% of Ketoconazole (Nizoral) Shampoo 2%-treated subjects. Adverse reactions that occurred in <1% of Ketoconazole (Nizoral) Shampoo 2%-treated subjects in the clinical datasets are listed in Table 1. (See Table 1.)
Click on icon to see table/diagram/image
Postmarketing data: In addition to the adverse reactions reported during clinical studies and listed previously, the following adverse reactions have been reported during postmarketing experience. In each table, the frequencies are provided according to the following convention: Very common ≥ 1/10, Common ≥ 1/100 and < 1/10, Uncommon ≥ 1/1000 and < 1/100, Rare ≥ 1/10000 and < 1/1000, Very rare < 1/10000, including isolated reports. (See Table 2.)
Click on icon to see table/diagram/image
View ADR Monitoring Form